睾丸受累是Apo A-I Leu75Pro突变型淀粉样变的标志性特征
该回顾性研究基于意大利布雷西亚大学医院参考中心前瞻性收集的129例男性Apo A-I Leu75Pro淀粉样变患者数据库,评估肝脏、肾脏功能、阴囊超声、生殖激素、睾丸活检、性腺功能减退症状及生育力。结果显示96/129例(74.4%)出现睾丸、肾脏和肝脏的进展性受累,其中睾丸受损88/129例(68.2%),常为首发表现,以原发性(73/88,83.0%)和亚临床(8/88,9.1%)性腺功能减退为特征,85/88例(96.6%)促卵泡激素升高,53/88例(60.2%)有大睾丸症。
要点
- 129例男性Apo A-I Leu75Pro淀粉样变患者中,睾丸受损88例(68.2%),肝脏59例(45.7%),肾脏50例(38.8%)。
- 睾丸损害常为首发表现,在30%的年轻患者(<38岁)中为唯一功能障碍。
- 睾丸受累以原发性性腺功能减退(73/88,83.0%)和亚临床性腺功能减退(8/88,9.1%)为主,85/88例(96.6%)促卵泡激素升高。
核心结论
- 在男性Apo A-I Leu75Pro淀粉样变患者中,睾丸受累是该病的标志性特征,以全面原发性睾丸功能障碍和大睾丸症为特点,大睾丸症由淀粉样物沉积所致。
研究设计与样本
- 回顾性研究,基于意大利布雷西亚大学医院参考中心前瞻性收集的数据库,纳入129例年龄>18岁的男性Apo A-I Leu75Pro淀粉样变患者。
主要发现
- 96/129例(74.4%)观察到睾丸、肾脏和肝脏的进展性受累;睾丸受损88/129例(68.2%),肝脏59例(45.7%),肾脏50例(38.8%)。
- 睾丸损害常为首发表现,在30%的年轻患者(<38岁)中为唯一功能障碍。
- 睾丸受累以原发性性腺功能减退(73/88,83.0%)和亚临床性腺功能减退(8/88,9.1%)为主;85/88例(96.6%)促卵泡激素升高,提示内分泌和生精功能全面原发性损害;30%的患者未能生育。
- 大睾丸症见于53/88例(60.2%),尤其在<54岁男性中(30/33,90.9%)。
- Apo A-I淀粉样物沉积见于支持细胞、生精上皮和血管壁。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Apo A-I Leu75Pro is a rare hereditary form of amyloidosis that mainly involves the kidney, the liver, and the testis. OBJECTIVE: To define the characteristics of organ damage and testis impairment in the largest cohort collected to date of men with Apo A-I Leu75Pro amyloidosis. DESIGN, SETTING, AND PATIENTS: Retrospective study from a prospectively collected database of 129 male subjects >18 years with Apo A-I Leu75Pro amyloidosis from a reference center at the University Hospital of Brescia, Italy. MAIN OUTCOME MEASURES: We evaluated liver and renal function, scrotal ultrasound, reproductive hormone levels, testis biopsy, hypogonadal symptoms, and fertility. RESULTS: Progressive involvement of testis, kidney, and liver was observed in 96/129 (74.4%) cases. Testis impairment was found in 88/129 patients (68.2%), liver in 59 (45.7%) and renal in 50 (38.8%). Testis damage was often the first manifestation of the disease and the only dysfunction in 30% of younger patients (<38 years). Testicular involvement was characterized mainly by primary (73/88 patients, 83.0%) and subclinical (8/88, 9.1%) hypogonadism. Almost all (85/88, 96.6%) also had high follicle-stimulating hormone, suggesting a primary global damage of endocrine and spermatogenic functions, and 30% of them did not conceive. Macroorchidism was found in 53/88 (60.2%) patients, especially in men <54 years (30/33, 90.9%). Apo A-I amyloid deposits were found in Sertoli cells, germinal epithelium, and vessel walls. CONCLUSION: In men with Apo A-I Leu75Pro amyloidosis, testicular involvement is the hallmark of the disease, characterized by global primary testicular dysfunction and macroorchidism due to amyloid deposits.
引用
- Delbarba A, Facondo P, Fisogni S, et al. Testicular Involvement is a Hallmark of Apo A-I Leu75Pro Mutation Amyloidosis. J Clin Endocrinol Metab. 2020. PMID: 32841328. doi:10.1210/clinem/dgaa587
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。